https://www.selleckchem.com/pr....oducts/tolebrutinib-
5%), "evidence is conclusive" (N=35; 6.4%), and "intervention no longer in general use" (N = 34; 6.2%). For the 269 (49%) Cochrane reviews, we considered that the justification for stabilization was not clearly described, that is, sufficiently informative. Cochrane reviews would benefit from more transparency and consistency in publicly available justifications for stabilizing reviews. Further work in this field will help make decisions about the futility of further research and deciding on enough evidence in the field of
Like
Comment
Share
